Epratuzumab
Top View
- (ESGICH) Consensus Document on the Safety of Targeted And
- Stembook 2018.Pdf
- Recent Biotherapies and Infections
- Contents Volume 73 Issue 1 | ARD January 2014 Editorial Viewpoint
- (INN) for Biological and Biotechnological Substances
- In Primary Sjögren's Syndrome
- Biosimilar Antibodies & ELISA Kits
- Belimumab Treatment for Adults with Systemic Lupus Erythematosus: a Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines
- July 2017 a View Into Upcoming Specialty and Traditional Drugs TABLE of CONTENTS
- Development of Therapeutic Antibody Technology and Recent
- Targeting B Cells to Treat Systemic Lupus Erythematosus
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
- Long‐Term Safety and Efficacy of Epratuzumab in The
- B-Cell-Targeted Therapies in Systemic Lupus Erythematosus
- Wo 2010/095940 A2
- New Antibody Approaches to Lymphoma Therapy Tejas Suresh1, Lisa X Lee1, Jitesh Joshi1 and Stefan K Barta2*
- Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: an Overview
- Antibody Purification by Cation Exchange Chromatography